SCHEMBL609237

SCHEMBL609237

[c]1ccc(Oc2cc[c]cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 5/20 0.40
KMT2A Q03164 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 2/20 0.40
CYP3A4 P08684 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
MAOA P21397 2/20 0.33
NR1H2 P55055 1/20 0.33
BAX Q07812 1/20 0.33
MAPT P10636 4/20 0.32
PARP15 Q460N3 1/20 0.32
PARP14 Q460N5 1/20 0.32
PARP10 Q53GL7 1/20 0.32
PARP16 Q8N5Y8 1/20 0.32
PARP11 Q9NR21 1/20 0.32
PARP4 Q9UKK3 1/20 0.32
TEAD4 Q15561 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10839908 0.88 ALDH1A1 (0.39) LTA4HTSHRALDH1A1KMT2ATDP1
SCHEMBL49434 0.88 LTA4H (0.67) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27917515 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27736985 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27824058 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27737034 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL8535186 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27870037 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL27832320 0.86 LTA4H (0.63) LTA4HTSHRKMT2AMEN1MAOA
SCHEMBL10409634 0.84 ALDH1A1 (0.70) TSHRALDH1A1KMT2ATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382588-A1 ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS BASF SE (DE) 2024-06-12 EP claimed
EP-2814831-B1 NEW QUATERNARY AMMONIUM SALTS, METHOD FOR PREPARATION AND APPLICATIONS THEREOF UNIV MEDYCZNY IM KAROLA MARCINKOWSKIEGO (PL) 2018-08-01 EP claimed
US-9169267-B2 Quaternary ammonium salts, method for preparation and applications thereof UNIWERSYTET MEDYCZNY IM. KAROLA MARCINKOWSKIEGO (PL) 2015-10-27 US claimed
US-20150080583-A1 QUATERNARY AMMONIUM SALTS, METHOD FOR PREPARATION AND APPLICATIONS THEREOF UNIWERSYTET MEDYCZNY IM. KAROLA MARCINKOWSKIEGO (PL) 2015-03-19 US claimed
EP-2814831-A1 NEW QUATERNARY AMMONIUM SALTS, METHOD FOR PREPARATION AND APPLICATIONS THEREOF Uniwersytet Medyczny Im. Karola Marcinkowskiego (PL) 2014-12-24 EP claimed
WO-2013115661-A1 NEW QUATERNARY AMMONIUM SALTS, METHOD FOR PREPARATION AND APPLICATIONS THEREOF UNIWERSYTET MEDYCZNY IM. KAROLA MARCINKOWSKIEGO (PL) 2013-08-08 WO claimed
US-7488517-B2 Method of producing porous nitrile rubber coated indoor athletic socks WHANG BRIAN 2009-02-10 US claimed
WO-2004067732-A2 POLYMER CARRIERS WITH BONDED SACCHARIDES FOR IMMOBILIZATION OF BIOLOGICAL SYSTEMS ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VEDCESKÉ REPUBLIKY (CZ) 2004-08-12 WO claimed
EP-0973735-A2 POLYAROMATIC ANTIVIRAL COMPOSITIONS PHARMACIA & UPJOHN COMPANY (US) 2000-01-26 EP claimed
US-5998567-A COMPOUND CONTAINING MULTIPLE ESTER GROUPS CLARIANT GMBH (DE) 1999-12-07 US claimed
US-5958983-A NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY AGAINST HERPES, TOPICAL ADMINISTRATION THEM TO TREAT PATIENTS WITH HERPES; WORK BY INHIBITING THE INITIATION OF HERPES VIRAL DNA SYNTHESIS IN HOST CELLS PHARMACIA & UPJOHN COMPANY (US) 1999-09-28 US claimed
WO-1998045259-A2 POLYAROMATIC ANTIVIRAL COMPOSITIONS PHARMACIA & UPJOHN COMPANY (US) 1998-10-15 WO claimed
EP-0007499-B1 PROCESS FOR FOAMING SYNTHETIC RESINS AND FOAMED SYNTHETIC RESINS OBTAINED ACCORDING TO THIS PROCESS CIBA-GEIGY AG (CH) 1982-11-10 EP claimed
US-4288560-A Process for foaming plastics CIBA-GEIGY CORPORATION (US) 1981-09-08 US claimed
EP-0007499-A1 Process for foaming synthetic resins and foamed synthetic resins obtained according to this process CIBA-GEIGY AG (CH) 1980-02-06 EP claimed
US-4066620-A COPOLYESTER CAPABLE OF FORMING ANISOTROPIC MELT AND SHAPED ARTICLES THEREOF E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-01-03 US claimed
US-3991014-A Polyesters of derivatives of hydroquinone and bis(carboxyphenyl)ether E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-11-09 US claimed
EP-4382588-A1 ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS BASF SE (DE) 2024-06-12 EP disclosed
US-4075165-A 2,2,6,6-TETRA-SUBSTITUTED-4-PIPERIDINOL CIBA-GEIGY CORPORATION (US) 1978-02-21 US disclosed
US-3991014-A Polyesters of derivatives of hydroquinone and bis(carboxyphenyl)ether E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080583-A1 QUATERNARY AMMONIUM SALTS, METHOD FOR PREPARATION AND APPLICATIONS THEREOF UFM1, UFL1, UBAP2L LTA4H 3375/4885TSHR 3244/4885ALDH1A1 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.